On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...